Utilizing Passively Collected Data in Daily Life to Enhance the Assessment and Treatment of Mental Health
Register via Zoom Dr. Nick Jacobson is a tenure-track assistant professor in the departments of Biomedical Data Science and Psychiatry within the Center for Technology and Behavioral Health in the Geisel School of Medicine at Dartmouth College. He directs the AI and Mental Health: Innovation in Technology Guided Healthcare (AIM HIGH) Laboratory. Dr. Jacobson researches […]
Recommendations for Culturally Recentering Reinforcement-Based Substance Use Disorder Interventions in Collaboration with Rural Tribal Communities
This presentation will cover ways to culturally adapt and implement contingency management among rural American Indian and Alaska Native communities. This will be achieved by describing evidence around substance use disorder (SUD) in rural American Indian and Alaska Native communities, discussing the importance of cultural adaptation for SUD treatment among members of rural Tribal communities, […]
Tobacco Regulations Across the Continuum of Harm
Tracy Smith, PhD Assistant Professor of Psychiatry and Behavioral Services Medical University of South Carolina The VCBH Monthly Lecture Series was originally created as an in-person series designed as a way to interact and engage with top researchers in the intersectional fields we often work with at VCBH including behavior change, addiction, chronic disease, […]
Alcohol Use Disorder (FAME Session #3)
Presenters: Abby Letcher, MD, FASAM; Angela Colistra, PhD, LPC, CAADC, CCS; Shanna Diaz, DO Series: This 2-hour, virtual-live session is part of the FAME 8-session series and will cover overdose prevention and harm reduction. The FAME series is a facilitated, in-depth discussion of real patient cases provided by participants with the opportunity to receive mentoring and feedback […]
The Connection Between Mental Health and Opioid Use Disorder
Presenter: Mark Duncan, MD, Assistant Professor, University of Washington, Director, UW Psychiatry and Addictions Case Conference Sponsor: American Psychiatric Association (APA) Cost: No Fee Target audience: Physicians, nurse practitioners or other advanced practice nurses, PAs, social workers, pharmacists, and healthcare teams Credit Designations Available: AAPA Category 1 CME, Social Work CE Credit, Nursing Contact Hours, Pharmacy CE […]
Comparing Methods of Buprenorphine Treatment Initiation in Patients Using Fentanyl
Presenter: Adam Bisaga, MD Target Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. This talk discusses substance use disorder treatment in a post-COVID world. Discussion is designed to promote interactivity through an informal "round table" conversation. Attendees will be given the opportunity to speak directly with the […]
Screening for Substance Use in Primary Care: Screening Tools and Guidance for Implementation
Presenter: Jennifer McNeely, MD Sponsor: American Psychiatric Association (APA) and American Academy of Addiction Psychiatry (AAAP) Cost: No Fee Target audience: Physicians, psychologists, social workers, physician assistants, pharmacists, interprofessional team, residents/fellows, medical […]
Illicit Drug Supply: Fentanyl and Xylazine
Presenter: Richard Dawson, PhD, Research Professor at the Vermont Center for Behavior and Health at UVM and a Professor Emeritus at the UCLA Department of Psychiatry This presentation will explore current […]
Substance Use Disorders in Late Life
Register Now Presenters: Roberto D. Sanchez, DO and Ali Abbas Asghar-Ali, MD Target Audience: This activity is designed for Psychiatrists, Physicians, Physician Assistants, Nurses/Nurse Practitioners, Social Workers, Psychologists, Pharmacists, […]
How Adding a Clinical Pharmacist Improves Access to Addiction Care
Register here Presenters: Ben Miskle, PharmD, University of Iowa Hospitals and Clinics Alison Lynch, MD, MS, University of Iowa Hospitals and Clinics Sponsor: American Academy of Addiction Psychiatry (AAAP) Cost: No […]
Nurses’ Practices with People Experiencing Opioid Use Disorder
Register Now Presenter: Timothy J. Sowicz, PhD, RN Cost: No Fee Target audience: This activity is designed for for Nurses, MAT Team Providers, Addictions Specialists, SUD Project Directors, Managers, and Facilitators. This […]
Co-occurring Opioid and Stimulant Use Disorders: Treatment and Management Approaches
Register Now Presenters: Jonathan Craig Allen, MD, FASAM, and Marc Fishman, MD Sponsor: National Council for Mental Wellbeing--NCMW Continuing education information: AMA PRA Category 1 Credit™, Nursing Contact Hours, AAPA […]
Three years of the COVID-19 Pandemic: What we’ve learned, and how it can make us better at treating rural patients with SUD
This presentation will explore lessons learned from the COVID-19 pandemic as they relate to rural populations with substance use disorder. Register and attend to learn more! Speaker: Sarah Jacobs, MD, […]
Treatment Considerations in the Age of Fentanyl
Fentanyl and other high-potency synthetic opioids are increasingly present in the U.S. drug supply. Healthcare systems, treatment providers, and justice systems are grappling with the physiological consequences of chronic fentanyl […]
Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Biobehavioral Mechanisms of an Evidence-Based Therapy for Chronic Pain, Opioid Misuse, and Opioid Use Disorder
Register Now Presenter: Eric Garland, PhD, LCSW Sponsoring organization: American Society for Pain Management Nursing (ASPMN) Target audience: Clinical providers including Physicians, PAs and NPs About the webinar: Half of all people […]
Initiating Buprenorphine for Patients Using Fentanyl
Register Now Presenter: Brian Hurley, MD, MBA, DFASAM, FAPA Cost: No Fee Target audience: Nurses, Addictions Specialists, SUD Project Directors, Managers, and Facilitators and MOUD (medications for opioid use disorder) providers Credit Designations […]
Xylazine and How it Harms People Who Use Drugs
Register now! Presenters: Raagini Jawa, MD Cost: No fee Target Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. Description: We will review […]
Opioid Use Disorder and Social Determinants of Health
Presenters: Rachel Talley, MD, Assistant Professor of Clinical Psychiatry/Director, Fellowship in Public and Community Psychiatry Jessica Isom, MD, Attending Psychiatrist, Codman Square Health Center/Clinical Instructor, Yale University/Faculty Lead, Social […]
Changing the Default: Moving to an Opt-Out Approach for Treating Tobacco Use Disorders
Join us on Wednesday, May 17th for the #VCBHLectureSeries as we welcome Kimber Richter, PhD, MPH, Professor of Population Health at the University of Kansas Medical Center. Dr. Richter will […]
Drug Use in Pregnancy (ASAM FAME Session 7)
Register Now Questions about registering should be directed to: ASAM Education by email ateducation@asam.org Presenters: Abby Letcher, MD, FASAM Angela Colistra, PhD, LPC, CAADC, CCS Shanna Diaz, DO Leslie Hayes, […]
Nurse Practitioners and Physician Assistants as Buprenorphine Providers: Facilitators and Barriers
This presentation will describe the expansion of nurse practitioners and other advanced practice clinicians into opioid use disorder treatment, particularly in rural communities. It will also explore barriers and facilitators […]
Opioid Use Disorder in Pregnant and Postpartum People: The Treatment and Policy Landscape
Register Now Presenters: Maria Manriquez, MD, FACOG, FASAM, PMH-C; Tara Sundem, APRN, NNP-BC; and Tawni Carson Sponsor: National Council for Mental Wellbeing--NCMW NOTE: The National Council for Mental Wellbeing will […]
Expanding Harm Reduction Access in the US for Rural and Other Underserved Populations
This presentation will describe research around syringe service programs and methods of harm reduction distribution. Specific considerations for reaching members of rural communities will be discussed. Learning objectives: 1. Discuss […]
A Qualitative Analysis of US State Laws Regulating Incentives for Health Behavior
This presentation will describe the results of a qualitative study examining state laws regulating incentives for health behavior. Such laws may have important implications for provision of contingency management for […]
Providing Comprehensive Care in Opioid Treatment Program: A Policy and Provider Perspective
Presenters: Mark Parrino, President and CEO of The American Association for the Treatment of Opioid Dependence, Inc. Jennifer Seib, VP of Strategic Initiatives and Integration at BestSelf Behavioral Health Sponsor: […]
Buprenorphine in the Age of Fentanyl: Discussing the New Guidance
Presenter: John Mariani, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round […]
Reaching People Where They’re At: Smoking Cessation Treatment Delivery at Your Door
This presentation will discuss novel ways to deliver evidence-based treatment for smoking cessation within and across rural areas. It will focus on 4 separate clinical trials of medication sampling, each […]
Clinical Primer and Discussion on Weekly and Monthly Injectable Buprenorphine
Presenter: Michelle Lofwall, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round […]
Buprenorphine Dosing and Preparations in the Era of Fentanyl
Presenters: Gail D’Onofrio, MD and Andrew Herring, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity […]
Addressing the Intersection of Pain Management and Opioid Use: Integrating Care to Promote Healthy Outcomes
This hybrid full-day training summit will explore the clinical intersection of pain and opioid use. Interdisciplinary attendees will learn about evidence-based practices (pharmacological and non) for treating these complex and […]